TLRY surges 44.1% on reports that Trump may reclassify marijuana, sparking hopes for eased federal rules and renewed investor enthusiasm.
President Trump is reportedly considering an executive order on marijuana reclassification. The order could come as early as Monday.
Tilray's stock, and shares of other cannabis companies, soared after reports provided investors hope that President Trump would move to have marijuana reclassified as a much less dangerous drug than it is now.
Tilray Brands Inc (NASDAQ:TLRY) stock is soaring today, after the Washington Post reported that U.S. President Donald Trump plans to reclassify marijuana and dramatically loosen restrictions.
The latest trading day saw Tilray Brands, Inc. (TLRY) settling at $7.2, representing a -2.04% change from its previous close.
Tilray's slump deepens as a tighter U.S. hemp rule and a reverse split stir uncertainty despite gains in global cannabis sales.
Tilray Brands, Inc. (TLRY) closed the most recent trading day at $0.78, moving 3.76% from the previous trading session.
Nearly six months ago, Tilray Brands (TLRY) stockholders approved a 1-for-10 reverse stock split. Now the cannabis firm has given a date it will take effect, and shares are tanking.
Tilray Brands, Inc. (TLRY) reached $0.98 at the closing of the latest trading day, reflecting a +1.89% change compared to its last close.
Tilray Brands' global expansion and strong Canadian momentum spotlight its edge as investors weigh upside against Cresco Labs' slower growth.
TLRY posts a sharp profitability turnaround in Q1 as cost control, efficiency gains and portfolio optimization boost results.
Tilray Brands, Inc. (TLRY) reached $1.03 at the closing of the latest trading day, reflecting a -5.09% change compared to its last close.